Lubrizol and Polyhose Inaugurate Medical Tubing Manufacturing Facility in Chennai

Lubrizol and Polyhose have opened an advanced medical tubing facility in Chennai to boost healthcare manufacturing, innovation, and MedTech capabilities.

Lubrizol and Polyhose have joined forces to establish a state-of-the-art medical tubing manufacturing facility in Chennai, Tamil Nadu. The new site will enhance India’s MedTech ecosystem by boosting local production of precision medical tubing for minimally invasive devices.

The new facility is dedicated to precision extruded medical tubing for neurovascular and cardiovascular applications. It will also help accelerate growth in India’s healthcare and medical technology sectors by enhancing local manufacturing capacity.

The plant also improves the reliability of supply to domestic and global customers, with faster access to critical medical components.

“Minimally invasive procedures are revolutionizing patient care.” -  Mittal Shah, Business Head, Medical Devices IMEA, Lubrizol

Polyhose Emphasizes Teamwork and Future Goals

The collaboration, according to Polyhose's founder and managing director Shabbir Yusuf Jamnagarwala, is a significant turning point in the business's development. He clarified that the delivery of cutting-edge medical tubing solutions is made possible by integrating Lubrizol's materials research skills with Polyhose's extrusion knowledge.

He also emphasized that the investment shows a sustained dedication to innovation, the development of skilled jobs, and India's rise to prominence as a reliable worldwide center for the production of medical devices. 

How it Help in the MedTech Manufacturing Industry?

Advanced medical tubing facility between Lubrizol & Polyhose represents a big step towards development of India’s MedTech manufacturing industry. The facility is intended to provide high-quality medical tubing products that are meant for use in medical devices, diagnostics, and healthcare equipment to increase the reliability and quality of those products.

In addition, CIO Bulletin observes that the facility will minimize India’s reliance on foreign medical parts, facilitate faster innovation of new healthcare solutions, and allow the development of the domestic supply chain.

Combining the technological capabilities of Lubrizol and Polyhose will enable them to contribute to healthcare innovations all over the world and make Chennai an emerging center for manufacturing of advanced medical technology products.